Flora Growth Current Deferred Revenue (Quarterly) Insights

Flora Growth Corp. (FLGC)

6.26 -0.07 (-1.11%) USD | NASDAQ | Dec 31, 16:00

6.215 -0.04 (-0.72%) Pre-Market: 20:00

View Current Deferred Revenue (Quarterly) for FLGC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

BioLife Solutions, Inc.	Upgrade
Tharimmune, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	--